The effect of isolated leukaemic blasts on platelet aggregation

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Acute myelogenous leukemia (AML) is characterized by the proliferation of myeloid blasts.
• Bleeding tendency is a common complication in AML patients.
• Platelet aggregation is crucial for hemostasis.

Purpose of the Study:

• To investigate the effect of AML blastic cells on normal platelet aggregation.
• To explore the potential mechanisms by which blastic cells influence platelet function.
• To determine if blastic cells contribute to bleeding complications in AML.

Main Methods:

• Isolation of blastic cells from non-treated AML patients using Böyum's method.
• Assessment of platelet aggregation induced by ADP, collagen, and epinephrine in the presence of blastic cells.
• Evaluation of the effect of metabolic poisons and cell membrane disruption on blastic cell-induced inhibition.
• Investigation of platelet prostaglandin biosynthesis.
• Attempts to prepare blastic cell-free platelet suspensions using albumin gradient and gel filtration.

Main Results:

• Blastic cells inhibited platelet aggregation induced by ADP and collagen at concentrations of 2,000/microliter and higher.
• Epinephrine-induced platelet aggregation was not affected by blastic cells.
• The inhibitory effect was independent of metabolic poisons or blastic cell membrane integrity.
• Results suggest blastic cells do not interfere with platelet prostaglandin biosynthesis.
• Preparation of blastic cell-free platelet suspensions was not feasible in patients with high leukocyte counts.
• Leukaemic blast presence in platelet suspensions may explain aggregation variations in AML patients.

Conclusions:

• AML blastic cells directly inhibit normal platelet aggregation.
• The presence of blastic cells in platelet preparations can lead to inaccurate aggregation assessments.
• Blastic cell-mediated platelet dysfunction is a significant factor contributing to the bleeding tendency in acute myelogenous leukemia.